SEC 13F Intelligence

Dsam Partners (London) Ltd / VRTX

Dsam Partners (London) Ltd’s Vertex Pharmaceuticals Inc Position

Does Dsam Partners (London) Ltd own Vertex Pharmaceuticals Inc (VRTX)? Not currently — the last reported position was 39.5K shares worth $9M in Q4 2020; the fund’s latest 13F (Q3 2021) no longer reports it.

Position Value
$9M
Q4 2020
Shares
39.5K
% of Portfolio
+1.09%
Quarters Held
1
position exited

Position History VRTX

Reported value by quarter
Q4 ’20: $9MQ4 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202039.5K$9M+1.09%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Dsam Partners (London) Ltd’s full portfolio or all institutional holders of VRTX.